Neuro-oncology
News
Bevacizumab plus irinotecan beats temozolomide in stalling glioblastoma
Major finding: The 6-month progression-free survival 6 months after randomization was 79.6% for patients treated with bevacizumab and irinotecan...
News
Manage most SEGAs with rapamycin analogs, not surgery
Major finding: Rapamycin analogs shrink SEGA tumors by more than 50% in a majority of children, and obviate the need for surgery. Data source:...
News
Duloxetine reduces chemo-induced neuropathy
Major finding: Study subjects were 2.4 times more likely to experience a 50% pain reduction while taking duloxetine than while taking placebo.Data...
News
'Chemobrain' starts before chemotherapy in breast cancer study
Major Finding: Women scheduled to undergo chemotherapy after surgery for breast cancer were significantly more likely to show low brain activation...
News
PET/CT Pinpoints Physiological Evidence of Chemo Brain
Major Finding: Statistically significant declines in glucose metabolism were observed post chemotherapy in the superior medial frontal gyrus as a...
News
Early Surgery Yields Survival Benefit for Low-Grade Gliomas
Major Finding: Overall mortality was 52% with watchful waiting and 32% with early resection; median survival was 5.9 years in the first group but...
News
Memantine Protects Cognitive Function After Whole Brain Irradiation
Major Finding: Cancer patients with brain metastases had a 17% relative reduction in cognitive decline after whole brain radiation if they took...
News
Can Lapatinib Prevent Brain Metastases from Breast Cancer? Data 'Inconclusive'
Major Findings: The primary end point of CNS as first site of relapse was no different comparing lapatinib-capecitabine (3%) vs. trastuzumab-...
News
Acetyl-l-Carnitine Yields Mixed Results for Chemo-Induced Neuropathy
Major Finding: Patients taking ALC for prevention were more likely to have a greater than 5-point worsening of FACT-NTX score (38% vs. 28%),...